Ying Lin

11.2k citations
232 papers · 9.1k · 2 hit papers · h-index 44

Impact in

    • MicroRNA in disease regulation
    • Breast Cancer Treatment Studies
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Breast Cancer Treatment Studies 23
    • MicroRNA in disease regulation 9
    • Cancer Risks and Factors 10
    • Cancer Immunotherapy and Biomarkers 9
    • Chemokine receptors and signaling 8

Ying Lin

215 papers receiving 8.8k citations

Ying Lin's Hit Papers

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial 2024 · 97 citations
970+1+2Years since publication4080120

Peers

Ying Lin
Comparison fields: 5 of 156
  • Cancer Research 2.1k
  • Oncology 1.5k
  • Immunology 1.2k
  • Pharmacology 884
  • Molecular Biology 1.7k
Replace Zhiwei Li with:
Zhiwei Li China
Hui Liu China
Paloma Martín‐Sanz Spain
Athanasios G. Papavassiliou Greece
Lin Li China
Bagher Farhood Iran
Robert Daniel Beauchamp United States
Jingwen Zhang China
Nadir Arber Israel
Li Li China
Ying Lin relative to Zhiwei Li China Zhiwei Li's profile →
Citations per field
00.5×1.5×2.1×
Zhiwei Li · 1×
Citations per year

Countries citing papers authored by Ying Lin

Since Specialization
Citations

This map shows the geographic impact of Ying Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Lin more than expected).

Fields of papers citing papers by Ying Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Lin. The network helps show where Ying Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Ying Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ying Lin Line = papers co-authored together Ying Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2009585
2 2005493
3 2009489
4 2000415
5 2009334
6 2006240
7 2019228
8 2002222
9 2009208
10 2001206
11
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
2003202
12 1999197
13 2001197
14 2017194
15 2004184
16 2020162
17 2008125
18 2003124
19
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study
Hit paper breakdown →
2023121
20 2004116

About Ying Lin

Ying Lin is a scholar working on Cancer Research, Oncology, Pharmacology, Immunology and Genetics, having authored 232 papers that have together received 9.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Cancer Risks and Factors (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), MicroRNA in disease regulation (9 papers), Chemokine receptors and signaling (8 papers), Inflammatory mediators and NSAID effects (8 papers), Genetic Associations and Epidemiology (8 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.5k citations), Immunology (1.2k citations), Pharmacology (884 citations) and Molecular Biology (1.7k citations). Ying Lin has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Sherven P. Sharma, Steven M. Dubinett, Yunhui Cheng, Jian Yang, Chunxiang Zhang, Xiaojun Liu, Mariam Dohadwala, Jie Luo, Shuo Zhang and Ruochun Huang. Their work appears in journals such as Cancer Letters, Cancer Research, Journal of Biological Chemistry, International Journal of Cancer and EClinicalMedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact